journal article·2022-11-22

Multifunctional Magnetic Nanoclusters Can Induce Immunogenic Cell Death and Suppress Tumor Recurrence and Metastasis

Linlin Zhang, Qingbo Zhang, Daniel T. Hinojosa, Kaiyi Jiang, Quoc-Khanh Pham, Zhen Xiao, Vicki L. Colvin, Gang Bao

ACS Nano· Volume 16· Issue 11
Publisher page

Abstract

Metastasis is the predominant cause of cancer deaths due to solid organ malignancies; however, anticancer drugs are not effective in treating metastatic cancer. Here we report a nanotherapeutic approach that combines magnetic nanocluster-based hyperthermia and free radical generation with an immune checkpoint blockade (ICB) for effective suppression of both primary and secondary tumors. We attached 2,2'-azobis(2-midinopropane) dihydrochloride (AAPH) molecules to magnetic iron oxide nanoclusters (IONCs) to form an IONC-AAPH nanoplatform. The IONC can generate a high level of localized heat under an alternating magnetic field (AMF), which decomposes the AAPH on the cluster surface and produces a large number of carbon-centered free radicals. A combination of localized heating and free radicals can effectively kill tumor cells under both normoxic and hypoxic conditions. The tumor cell death caused by the combination of magnetic heating and free radicals led to the release or exposure of various damage-associated molecule patterns, which promoted the maturation of dendritic cells. Treating the tumor-bearing mice with IONC-AAPH under AMF not only eradicated the tumors but also generated systemic antitumor immune responses. The combination of IONC-AAPH under AMF with anti-PD-1 ICB dramatically suppressed the growth of untreated distant tumors and induced long-term immune memory. This IONC-AAPH based magneto-immunotherapy has the potential to effectively combat metastasis and control cancer recurrence.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Heme Oxygenase-1 and Carbon Monoxide · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering, Rice University, Houston, Texas 77030, United States

Department of Chemistry, Brown University, Providence, Rhode Island 02912, United States

Funding

National Cancer Institute · Cancer Prevention and Research Institute of Texas

References (67)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.3389/fonc.2021.65996310.3389/fonc.2021.659963 ↗
3. 10.1038/nrc.2016.2510.1038/nrc.2016.25 ↗
4. 10.2174/15680091179565592110.2174/156800911795655921 ↗
5. 10.1016/S0140-6736(98)90327-010.1016/S0140-6736(98)90327-0 ↗
6. 10.1038/s41577-020-0306-510.1038/s41577-020-0306-5 ↗
7. 10.1016/j.intimp.2018.06.00110.1016/j.intimp.2018.06.001 ↗
8. 10.1016/j.immuni.2016.06.00110.1016/j.immuni.2016.06.001 ↗
9. 10.1126/science.aaa496710.1126/science.aaa4967 ↗
10. 10.1038/s41573-019-0038-z10.1038/s41573-019-0038-z ↗
11. 10.1038/s41416-020-01160-510.1038/s41416-020-01160-5 ↗
12. 10.1016/j.ccell.2018.03.00510.1016/j.ccell.2018.03.005 ↗
13. 10.1093/annonc/mdy55110.1093/annonc/mdy551 ↗
14. 10.3390/cancers1304067810.3390/cancers13040678 ↗
15. 10.3389/fimmu.2020.59520710.3389/fimmu.2020.595207 ↗
16. 10.1002/adfm.20180468810.1002/adfm.201804688 ↗
17. 10.20517/2394-4722.2017.3510.20517/2394-4722.2017.35 ↗
18. 10.1038/ncomms1319310.1038/ncomms13193 ↗
19. 10.1038/s41467-018-03473-910.1038/s41467-018-03473-9 ↗
20. 10.1002/advs.20170089110.1002/advs.201700891 ↗
21. 10.1002/adma.20140299610.1002/adma.201402996 ↗
22. 10.1002/advs.20200250410.1002/advs.202002504 ↗
23. 10.1016/j.addr.2018.10.01610.1016/j.addr.2018.10.016 ↗
24. 10.1021/acs.nanolett.9b0057910.1021/acs.nanolett.9b00579 ↗
25. 10.1021/acsnano.9b0197910.1021/acsnano.9b01979 ↗
26. 10.1021/jacs.1c0253710.1021/jacs.1c02537 ↗
27. 10.1016/j.nantod.2017.02.00610.1016/j.nantod.2017.02.006 ↗
28. 10.3109/0265673090333395810.3109/02656730903333958 ↗
29. 10.3390/antiox912118810.3390/antiox9121188 ↗
30. 10.1021/acsnano.7b0911210.1021/acsnano.7b09112 ↗
31. 10.1002/adma.20180224410.1002/adma.201802244 ↗
32. 10.1021/acsnano.7b0071510.1021/acsnano.7b00715 ↗
33. 10.1016/j.nantod.2020.10100910.1016/j.nantod.2020.101009 ↗
34. 10.3389/fendo.2021.74221510.3389/fendo.2021.742215 ↗
35. 10.1002/cam4.359210.1002/cam4.3592 ↗
36. 10.1002/smtd.20200108710.1002/smtd.202001087 ↗
37. 10.1021/acs.nanolett.1c0000910.1021/acs.nanolett.1c00009 ↗
38. 10.1002/anie.20170289810.1002/anie.201702898 ↗
39. 10.1002/anie.20170315910.1002/anie.201703159 ↗
40. 10.1080/0265673021016653710.1080/02656730210166537 ↗
41. 10.1080/107157603100008829210.1080/1071576031000088292 ↗
42. 10.1016/j.surg.2007.03.01310.1016/j.surg.2007.03.013 ↗
43. 10.1021/acsami.0c0977810.1021/acsami.0c09778 ↗
44. 10.1002/jps.2257810.1002/jps.22578 ↗
45. 10.1002/jat.374910.1002/jat.3749 ↗
46. 10.1186/s13014-015-0462-010.1186/s13014-015-0462-0 ↗
47. White M. G. · 2007 · 162 · 34710.1016/S0079-6123(06)62017-7 ↗
48. 10.1016/j.jcis.2021.05.14410.1016/j.jcis.2021.05.144 ↗
49. 10.1080/107157603100008829210.1080/1071576031000088292 ↗
50. 10.1016/j.canlet.2011.12.02510.1016/j.canlet.2011.12.025 ↗
51. Nagelkerke A. · 2016 · 899 · 1
52. 10.2217/bmm.15.210.2217/bmm.15.2 ↗
53. 10.21769/BioProtoc.312810.21769/BioProtoc.3128 ↗
54. 10.1016/j.mam.2008.08.00610.1016/j.mam.2008.08.006 ↗
55. 10.1042/BJ2014066910.1042/BJ20140669 ↗
56. 10.1016/j.numecd.2005.05.00310.1016/j.numecd.2005.05.003 ↗
57. 10.1111/jcmm.1435610.1111/jcmm.14356 ↗
58. 10.3389/fimmu.2017.0054410.3389/fimmu.2017.00544 ↗
59. 10.1002/advs.20200108810.1002/advs.202001088 ↗
60. 10.1021/acsnano.9b0598510.1021/acsnano.9b05985 ↗
61. 10.1016/j.biomaterials.2016.04.00610.1016/j.biomaterials.2016.04.006 ↗
62. 10.3390/photochem103002610.3390/photochem1030026 ↗
63. 10.1016/j.ctrv.2015.03.01110.1016/j.ctrv.2015.03.011 ↗
64. 10.1002/advs.20180215710.1002/advs.201802157 ↗
65. 10.1186/s13045-018-0647-810.1186/s13045-018-0647-8 ↗
66. 10.1038/nrc.2018.610.1038/nrc.2018.6 ↗
67. 10.1016/j.jconrel.2014.06.02410.1016/j.jconrel.2014.06.024 ↗